Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation

Y Ren, H Zhao, C Yin, X Lan, L Wu, X Du… - Frontiers in …, 2022 - frontiersin.org
Chronic low-grade inflammation in adipose tissue (AT) is a hallmark of obesity and
contributes to various metabolic disorders, such as type 2 diabetes and cardiovascular …

Extracellular matrix remodeling of adipose tissue in obesity and metabolic diseases

FJ Ruiz-Ojeda, A Méndez-Gutiérrez… - International journal of …, 2019 - mdpi.com
The extracellular matrix (ECM) is a network of different proteins and proteoglycans that
controls differentiation, migration, repair, survival, and development, and it seems that its …

Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors

EE Mulvihill, DJ Drucker - Endocrine reviews, 2014 - academic.oup.com
Abstract Dipeptidyl peptidase-4 (DPP4) is a widely expressed enzyme transducing actions
through an anchored transmembrane molecule and a soluble circulating protein. Both …

DPP4 in diabetes

D Röhrborn, N Wronkowitz, J Eckel - Frontiers in immunology, 2015 - frontiersin.org
Dipeptidyl-peptidase 4 (DPP4) is a glycoprotein of 110 kDa, which is ubiquitously expressed
on the surface of a variety of cells. This exopeptidase selectively cleaves N-terminal …

Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions

S Shao, QQ Xu, X Yu, R Pan, Y Chen - Pharmacology & therapeutics, 2020 - Elsevier
Abstract Dipeptidyl peptidase 4 (DPP4) inhibitors (DPP4is) are oral anti-diabetic drugs
(OADs) for the treatment of type 2 diabetes mellitus (T2DM) through inhibiting the …

COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?

MF Bassendine, SH Bridge, GW McCaughan… - Journal of …, 2020 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic is caused by a novel
betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), similar …

Anti‐inflammatory Effects of Empagliflozin and Gemigliptin on LPS‐Stimulated Macrophage via the IKK/NF‐κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways

N Lee, YJ Heo, SE Choi, JY Jeon… - Journal of …, 2021 - Wiley Online Library
Background. Sodium‐glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase‐4 (DPP‐4)
inhibitors are glucose‐lowering drugs whose anti‐inflammatory properties have recently …

Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies

MA McArdle, OM Finucane, RM Connaughton… - Frontiers in …, 2013 - frontiersin.org
Obesity and associated chronic inflammation initiate a state of insulin resistance (IR). The
secretion of chemoattractants such as MCP-1 and MIF and of cytokines IL-6, TNF-α, and IL …

Identification of senescent cell surface targetable protein DPP4

KM Kim, JH Noh, M Bodogai, JL Martindale… - Genes & …, 2017 - genesdev.cshlp.org
Senescent cell accumulation in aging tissues is linked to age-associated diseases and
declining function, prompting efforts to eliminate them. Mass spectrometry analysis revealed …

DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications?

I Valencia, C Peiro, O Lorenzo… - Frontiers in …, 2020 - frontiersin.org
COVID-19 outbreak, caused by severe acute respiratory syndrome (SARS)-CoV-2
coronavirus has become an urgent health and economic challenge. Diabetes is a risk factor …